Yemmie Oluwatosin

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Yemmie Oluwatosin is an author at AstraZeneca (United States) specializing in renin-angiotensin-aldosterone system inhibition, pharmacology, and end-stage kidney disease management.

Publications per year

2023–2023

Publications

Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study

Abiy Agiro, Amin AN, Erin Cook et al. · Advances in Therapy · 2023 · 25 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes

Jaejin An, Hui Zhou, Liang Ni et al. · American Journal of Nephrology · 2023 · 20 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

1–2 of 2